The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.70
Bid: 23.00
Ask: 24.40
Change: 0.00 (0.00%)
Spread: 1.40 (6.087%)
Open: 23.70
High: 23.70
Low: 23.70
Prev. Close: 23.70
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jan 2022 07:00

RNS Number : 8685Y
Mission Group PLC (The)
19 January 2022
 

19 January 2022

THE MISSION GROUP plc

 

("MISSION", "the Group") 

 

TRADING UPDATE AND NOTICE OF RESULTS

The MISSION Group plc (AIM: TMG), creator of Work That Counts comprising a network of 16 Agencies delivering real, sustainable growth for its Clients, today issues a trading update for the year ended 31 December 2021.

Trading update

 

MISSION continued to deliver an impressive and strong sequential trading recovery throughout the second half of the financial year. As a direct consequence, the Group was pleased to achieve an outstanding increase in profit levels against both H1 2021 and FY2020 and so expects a healthy full year headline PBT performance that is in line with market expectations.

 

Whilst trading conditions throughout 2021 remained challenging, due to the impact and disruption caused by the evolving pandemic on the Group's markets, the resilience of MISSION'S business model has underpinned its continued ability to deliver against this backdrop.

Further strategic progress has been made over the course of the year to expand MISSION'S Agency portfolio with the acquisition of Soul, a full-service customer engagement Agency that works with psychologists to help businesses better understand human nature and human behaviour, enhancing MISSION's creative and customer experience capability.

The Group has also benefitted from a full year of the now fully embedded behavioural science practice, Innovation Bubble, acquired in 2020. MISSION expects to continue to grow its roster of Agencies in 2022, alongside investing in building additional and enhanced capability to further support its Clients.

The development of its people also continues to be of key strategic importance to the Group and in 2022 MISSION will invest at record levels in recruiting and retaining the best talent. Whilst the Group recognises this will have some short-term impact on its cost base, it will ultimately underpin its ability to deliver in future years.

Strong cash management remains a key priority for the Group and, even after settling its last significant earn-out obligation, its year end net bank debt was £10.2m, in line with market expectations and giving MISSION significant headroom against its current debt facility. The highly cash generative nature of the Group means it is well placed to capitalise on the opportunities that 2022 will undoubtedly bring.

Whilst uncertainties remain about Covid-19 and its impact on the economy over the current year, the Board is confident that the Group is well positioned for sustainable growth and expects to achieve double-digit year on year PBT growth in 2022.

 

Notice of results

 

The Group expects to announce its final results on 29 March 2022.

James Clifton, Chief Executive of The MISSION Group plc, commented: "I am pleased that MISSION's strong trading momentum has continued, demonstrating our continued ability to deliver growth against an ever changing and challenging backdrop.

"Over the course of the year we have further strengthened the Group and our market proposition, meaning we are increasingly well positioned to continue to progress against our strategic priorities in 2022 and beyond. The coming year will see us place a significant focus on our biggest and most important asset - our people - as we look to recruit and retain the best talent to provide the best service to our Clients."

 

ENQUIRIES:

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

 

020 7462 1415

 

 

Mark Percy / James Thomas / Fiona Conroy

Shore Capital (Nomad and Broker)

020 7408 4090

 

 

 

Kate Hoare / Laura Stewart

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

NOTES TO EDITORS

 

MISSION is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit. Employing 1,000 people across 27 locations and 3 continents, the Group successfully combines its diverse expertise to produce Work That Counts for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands. www.themission.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWRBRUNUAAAR
Date   Source Headline
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition
25th Sep 20197:00 amRNSChange of Name
25th Sep 20197:00 amRNSHalf-year Report
13th Aug 20197:00 amRNSEBT Share Dealings
7th Aug 20198:15 amRNSEBT Share Dealings
1st Aug 20191:11 pmRNSDirector/PDMR Shareholding - Replacement
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSTrading Update
17th Jun 201912:57 pmRNSResult of AGM
17th Jun 201911:58 amRNSBoard Changes
12th Jun 20195:26 pmRNSDirector/PDMR Shareholding
7th Jun 20199:34 amRNSEBT Share Dealings
6th Jun 20191:17 pmRNSEBT Share Dealings
5th Jun 201912:03 pmRNSEBT Share Dealings
4th Jun 20197:00 amRNSGrowth Share Scheme
20th May 20195:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20192:36 pmRNSDirector/PDMR Shareholding
23rd Apr 20199:53 amRNSDirector/PDMR Shareholding
9th Apr 20197:01 amRNSIssue of Equity
9th Apr 20197:00 amRNSFinal Results & Board Changes
22nd Jan 20197:00 amRNSTrading update and Notice of results
5th Dec 20181:43 pmRNSDirector/PDMR Shareholding
23rd Nov 20185:25 pmRNSDirector/PDMR Shareholding
15th Nov 20187:00 amRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSDisposal
19th Sep 20187:00 amRNSHalf-year Report
26th Jul 20187:00 amRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSTrading update and notice of interim results
10th Jul 20187:00 amRNSBoard changes
19th Jun 20182:33 pmRNSResult of AGM
22nd May 20182:11 pmRNSEBT Share Dealings
22nd May 20182:11 pmRNSHolding(s) in Company
9th May 20182:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.